Hims weekly recap highlights branded GLP-1 shift, token liquidity
Recap covering Hims & Hers Health’s pivot to branded GLP-1s via a Novo Nordisk deal for Wegovy and Ozempic, plus commentary on thin liquidity and weak price discovery in its on-chain token listing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.